Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

550 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of coronary intravascular lithotripsy for the treatment of calcified nodules: a pooled analysis of the Disrupt CAD studies.
Ali ZA, Shin D, Singh M, Malik S, Sakai K, Honton B, Kereiakes DJ, Hill JM, Saito S, Mario CD, Gonzalo N, Riley RF, Maehara A, Matsumura M, Hokama J, West NEJ, Stone GW, Shlofmitz RA. Ali ZA, et al. Among authors: kereiakes dj. EuroIntervention. 2024 Dec 2;20(23):e1454-e1464. doi: 10.4244/EIJ-D-24-00282. EuroIntervention. 2024. PMID: 39618263 Free article.
Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Lesions: 1-Year Results From the Disrupt CAD III Study.
Kereiakes DJ, Hill JM, Shlofmitz RA, Klein AJ, Riley RF, Price MJ, Herrmann HC, Bachinsky W, Waksman R, Stone GW; Disrupt CAD III Investigators. Kereiakes DJ, et al. J Soc Cardiovasc Angiogr Interv. 2022 Jan 30;1(1):100001. doi: 10.1016/j.jscai.2021.100001. eCollection 2022 Jan-Feb. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39130140 Free PMC article.
The Supreme Biodegradable Polymer DES in Acute and Chronic Coronary Syndromes: A PIONEER III Substudy.
Hussain Y, Saito S, Curtis M, Kereiakes DJ, Baumbach A, Zidar JP, McLaurin B, Dib N, Smits PC, Jiménez Díaz VA, Cequier Á, Hofma SH, Pietras C, Dressler O, Issever MO, Windecker S, Leon MB, Lansky AJ; PIONEER III Trial Investigators. Hussain Y, et al. Among authors: kereiakes dj. J Soc Cardiovasc Angiogr Interv. 2023 Mar 27;2(3):100629. doi: 10.1016/j.jscai.2023.100629. eCollection 2023 May-Jun. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39130696 Free PMC article.
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.
Reynolds HR, Page CB, Shaw LJ, Berman DS, Chaitman BR, Picard MH, Kwong RY, Min JK, Leipsic J, Mancini GBJ, Budoff MJ, Hague CJ, Senior R, Szwed H, Bhargava B, Celutkiene J, Gadkari M, Bainey KR, Doerr R, Ramos RB, Ong P, Naik SR, Steg PG, Goetschalckx K, Chow BJW, Scherrer-Crosbie M, Phillips L, Mark DB, Spertus JA, Alexander KP, O'Brien SM, Boden WE, Bangalore S, Stone GW, Maron DJ, Hochman JS; ISCHEMIA Research Group. Reynolds HR, et al. Circ Cardiovasc Interv. 2024 Dec;17(12):e013743. doi: 10.1161/CIRCINTERVENTIONS.123.013743. Epub 2024 Dec 17. Circ Cardiovasc Interv. 2024. PMID: 39689188 Clinical Trial.
Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy.
Patel KP, Lansky AJ, Kereiakes DJ, Windecker S, Cristea E, Pietras C, Dressler O, Issever MO, Curtis M, Bertolet B, Zidar JP, Smits PC, Jiménez Díaz VA, McLaurin B, Brogno DA, Janssens L, Vrolix MC, Gómez-Blázquez I, Sahul ZH, Kabour A, Salido L, Cleman M, Saito S, Leon MB, Baumbach A; PIONEER III Trial Investigators. Patel KP, et al. Among authors: kereiakes dj. J Soc Cardiovasc Angiogr Interv. 2022 Jan 30;1(1):100004. doi: 10.1016/j.jscai.2021.100004. eCollection 2022 Jan-Feb. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39130138 Free PMC article.
Geographic Variations on the Safety and Efficacy of the Supreme Biodegradable Polymer DES: Results From PIONEER III.
Garot P, Leon MB, Saito S, Baumbach A, Kereiakes DJ, Windecker S, Pietras C, Dressler O, Issever MO, Curtis M, Bertolet BD, Zidar JP, Smits PC, Jiménez Diaz VA, McLaurin B, Cequier AR, Hofma SH, Dib N, Namiki A, Takahashi A, Kakuta T, Hirohata A, Lansky AJ. Garot P, et al. Among authors: kereiakes dj. J Soc Cardiovasc Angiogr Interv. 2022 Nov 25;2(1):100515. doi: 10.1016/j.jscai.2022.100515. eCollection 2023 Jan-Feb. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39132534 Free PMC article.
Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus.
Thomas A, Kereiakes DJ, Baumbach A, Windecker S, Pietras C, Dressler O, Issever MO, Curtis M, Bertolet B, Zidar JP, Smits PC, Jiménez Díaz VA, McLaurin B, Cequier Á, Takahashi A, Cannon LA, Amoroso G, Kakuta T, Saito S, Leon MB, Lansky AJ. Thomas A, et al. Among authors: kereiakes dj. J Soc Cardiovasc Angiogr Interv. 2022 Apr 11;1(2):100033. doi: 10.1016/j.jscai.2022.100033. eCollection 2022 Mar-Apr. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39132558 Free PMC article.
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME Investigators. Zinman B, et al. N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17. N Engl J Med. 2015. PMID: 26378978 Free article. Clinical Trial.
550 results